Complete Filing Data
COSCIENS Biopharma Inc. reported Cash And Cash Equivalents of $7.31 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean COSCIENS Biopharma Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit Loss From Operating Activities | -$10.7M | -$18.3M | -$4.6M | $4.3M | -$8.7M | -$5.7M | -$10.2M | $9.8M | -$23.1M | -$29.5M | -$34.9M |
| Profit Loss | -$10.4M | -$15.3M | -$3.5M | $4.4M | -$8.4M | -$5.1M | -$6.0M | $4.2M | -$16.8M | -$25.0M | -$50.1M |
| Research And Development Expense | $3.0M | $8.3M | $2.0M | $1.4M | $6.6M | $1.5M | $1.8M | $2.9M | $10.7M | $16.5M | $17.2M |
| Other Comprehensive Income Net Of Tax Exchange Differences On Translation | -$961.0K | -$771.0K | $492.0K | -$1.7M | $367.0K | -$1.1M | $83.0K | -$260.0K | -$1.4M | $569.0K | $1.5M |
| Comprehensive Income | -$9.4M | -$17.2M | -$3.0M | $1.8M | -$11.6M | -$6.9M | -$7.0M | $4.1M | -$17.5M | -$25.9M | -$47.8M |
| Cost Of Sales | $4.9M | $4.9M | $4.2M | $6.0M | $90.0K | $2.3M | $410.0K | $2.1M | $0.00 | $0.00 | |
| Profit Loss Before Tax | -$10.3M | -$15.2M | -$4.4M | $4.5M | -$8.5M | -$4.7M | -$6.2M | $9.6M | -$20.3M | -$25.0M | -$50.2M |
| Other Comprehensive Income Net Of Tax Gains Losses On Remeasurements Of Defined Benefit Plans | $2.0M | -$1.2M | -$1.2M | $5.3M | -$3.6M | -$650.0K | -$1.1M | $193.0K | $694.0K | -$1.5M | $844.0K |
| General And Administrative Expense | $8.7M | $8.2M | $7.3M | $5.9M | $6.6M | $8.9M | $8.2M | $7.1M | $11.3M | ||
| Income Tax Expense Continuing Operations | $10.0K | $84.0K | -$885.0K | $1.1M | -$109.0K | $395.0K | -$188.0K | $5.5M | -$3.5M | $0.00 | $0.00 |
| Revenue From Royalties | $68.0K | $67.0K | $45.0K | $184.0K | $0.00 | $0.00 | |||||
| Income Taxes Paid Refund | -$1.3M | -$831.0K | $1.6M | -$1.4M | |||||||
| Supply Chain Revenue | $185.0K | $304.0K | $284.0K | $95.0K | |||||||
| Gross Profit | $2.6M | $4.7M | $2.9M | $11.0M | $24.8M | $923.0K | $911.0K | ||||
| Shortterm Restructuring Provision | $34.0K | $92.0K | $418.0K | $887.0K | $2.5M | $33.0K | |||||
| Revenue From Sale Of Goods | $2.4M | $129.0K | $2.2M | $0.00 | $0.00 | ||||||
| Reversal Of Provisions For Cost Of Restructuring | -$511.0K | $136.0K | -$3.1M | $8.0K | -$932.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $7.3M | $16.4M | $6.7M | $10.2M | $6.2M | $24.3M | $7.8M | $14.5M | $7.8M | $22.0M | $41.5M | $34.9M |
| Equity Attributable To Owners Of Parent | $3.8M | $13.2M | $21.0M | $23.8M | $21.9M | $13.2M | -$2.5M | $1.9M | -$2.8M | $6.2M | $21.6M | $14.5M |
| Cash Flows From Used In Operating Activities | -$8.5M | -$14.6M | -$2.6M | $5.2M | -$8.6M | -$4.1M | -$10.7M | $6.8M | -$22.9M | -$29.0M | -$33.8M | |
| Cash Flows From Used In Financing Activities | -$407.0K | -$588.0K | -$357.0K | -$267.0K | $51.0M | $20.5M | $3.9M | $0.00 | $8.0M | $9.9M | $40.8M | |
| Cash Flows From Used In Investing Activities | -$458.0K | $25.1M | -$730.0K | -$304.0K | -$658.0K | $56.0K | $50.0K | -$35.0K | $307.0K | -$314.0K | $913.0K | |
| Adjustments For Amortization Of Deferred Income | -$113.0K | -$856.0K | -$1.6M | -$1.7M | -$1.7M | $1.3M | $74.0K | $609.0K | $458.0K | $345.0K | $248.0K | |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $706.0K | $1.2M | $722.0K | $304.0K | $30.0K | $9.0K | $4.0K | $66.0K | $26.0K | |||
| Property Plant And Equipment | $9.8M | $11.0M | $11.6M | $216.0K | $216.0K | $22.0K | $35.0K | $65.0K | $101.0K | $204.0K | ||
| Liabilities | $17.6M | $21.9M | $2.7M | $4.0M | $27.1M | $23.8M | $22.4M | $23.1M | $25.0M | $25.4M | ||
| Assets | $21.4M | $35.1M | $23.7M | $37.7M | $80.1M | $37.0M | $20.0M | $25.0M | $22.2M | $31.7M | ||
| Retained Earnings | -$20.5M | -$12.1M | $4.4M | -$352.1M | -$334.6M | -$322.7M | -$316.9M | -$309.8M | -$314.2M | -$298.1M | ||
| Current Prepayments And Other Current Assets | $1.6M | $2.4M | $290.0K | $2.5M | $1.8M | $1.0M | $1.2M | $1.2M | $826.0K | $379.0K | ||
| Trade And Other Current Receivables | $1.3M | $2.4M | $290.0K | $732.0K | $1.3M | $1.7M | $658.0K | $294.0K | $221.0K | $365.0K | ||
| Restricted Cash And Cash Equivalents | $125.0K | $123.0K | $8.0K | $322.0K | $335.0K | $338.0K | $364.0K | $418.0K | $381.0K | $496.0K | ||
| Equity And Liabilities | $21.4M | $35.1M | $23.7M | $56.0M | $80.1M | $37.0M | $20.0M | $25.0M | $22.2M | $31.7M | ||
| Current Liabilities | $3.6M | $7.2M | $1.3M | $7.0M | $7.8M | $4.7M | $5.7M | $5.6M | $5.8M | $4.2M | ||
| Current Assets | $11.5M | $24.0M | $11.3M | $55.5M | $70.8M | $27.6M | $10.9M | $16.3M | $9.4M | $22.7M | ||
| Accumulated Other Comprehensive Income | -$2.4M | -$1.5M | -$712.0K | -$967.0K | -$678.0K | -$1.0M | $94.0K | $11.0K | $271.0K | $1.7M | ||
| Cash Flows From Used In Decrease Increase In Restricted Cash And Cash Equivalents | $4.0K | $207.0K | -$8.0K | -$1.0K | -$20.0K | $50.0K | $50.0K | -$50.0K | $150.0K | -$250.0K | $434.0K | |
| Noncurrent Lease Liabilities | $1.9M | $2.0M | $1.4M | $65.0K | $31.0K | $49.0K | $255.0K | |||||
| Current Tax Liabilities | $122.0K | $105.0K | $111.0K | $108.0K | $115.0K | $123.0K | $1.4M | $1.7M | $0.00 | |||
| Current Lease Liabilities | $215.0K | $271.0K | $299.0K | $114.0K | $130.0K | $135.0K | $648.0K | |||||
| Intangible Assets Other Than Goodwill | $7.0K | $9.0K | $625.0K | $59.0K | $40.0K | $62.0K | $90.0K | $70.0K | $237.0K | |||
| Goodwill | $8.1M | $8.8M | $8.1M | $8.2M | $8.6M | $7.6M | ||||||
| Other Equity Interest | $90.3M | $89.8M | $89.5M | $89.8M | $89.3M | $88.8M | $88.6M | |||||
| Gains Losses On Financial Liabilities At Fair Value Through Profit Or Loss | $1.1M | $4.5M | $263.0K | $2.2M | $4.4M | -$11.0M | ||||||
| Interest Accretion On Lease Liability | $4.0K | $7.0K | -$19.0K | $66.0K | ||||||||
| Trade And Other Current Payables Excluding Deferred Income Classified As Current | $2.7M | $2.2M | $2.1M | $2.8M | $2.8M | $3.7M | ||||||
| Issue Of Equity | $31.0M | $15.1M | $1.3M | $3.4M | $14.3M | |||||||
| Current Tax Assets Current | $114.0K | $121.0K | $1.4M | $2.4M | $601.0K | |||||||
| Current Accrued Expenses And Other Current Liabilities | $1.9M | $4.7M | $1.0M | $3.8M | $2.7M | |||||||
| Noncurrent Liabilities | $14.0M | $14.7M | $1.4M | $13.2M | $19.4M | |||||||
| Noncurrent Assets | $9.9M | $11.1M | $12.5M | $538.0K | $9.3M | |||||||
| Rightofuse Assets | $150.0K | $157.0K | $582.0K | |||||||||
| Adjustments For Gain Loss On Disposals Property Plant And Equipment | -$10.0K | $9.0K | $136.0K | $1.0K | $264.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Cash And Cash Equivalents | -$9.1M | $9.7M | -$3.5M | $4.0M | $41.0M | $16.4M | -$6.7M | $6.7M | -$14.2M | -$19.5M | $6.5M |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | $252.0K | -$212.0K | $157.0K | -$625.0K | -$769.0K | $38.0K | $108.0K | -$58.0K | $357.0K | -$51.0K | -$1.3M |
| Payments Of Lease Liabilities Classified As Financing Activities | $365.0K | $421.0K | $370.0K | $330.0K | $127.0K | $265.0K | $614.0K | ||||
| Increase Decrease In Working Capital | -$292.0K | $2.5M | -$58.0K | $936.0K | -$2.5M | $2.4M | $2.4M | $151.0K | $2.2M | $1.1M | $3.4M |
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | $244.0K | $1.0K | $6.0K | $24.0K | $161.0K | $2.0K | $505.0K | ||||
| Proceeds From Issue Of Ordinary Shares | 34.2M | 12.0M | 5.0M | 8.0M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Shares | 4.9M | 4.6M | 1.6M | 17.5M | 16.4M | 15.0M | 10.3M | 2.8M | |||
| Adjusted Weighted Average Shares | 114.9M | 41.1M | 17.5M | 17.0M | 15.0M | 10.3M | |||||
| Basic Earnings Loss Per Share | $-3.27 | $-5.93 | $-1.89 | $0.06 | $-1.82 | $-3.11 | $-0.35 | $0.25 | $-1.12 | $-2.41 | |
| Diluted Earnings Loss Per Share | $-3.27 | $-5.93 | $-1.89 | $0.06 | $-1.82 | $-0.12 | $-0.35 | $0.24 | $-1.12 | $-2.41 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Finance Income Cost | $333.0K | $3.1M | $259.0K | $208.0K | $194.0K | $983.0K | $4.0M | $1.2M | $2.8M | $4.5M | -$15.3M |
| Adjustments For Sharebased Payments | -$12.0K | $464.0K | $192.0K | $69.0K | $311.0K | $61.0K | $793.0K | $570.0K | $182.0K | $1.1M | $919.0K |
| Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss | -$196.0K | $48.0K | -$24.0K | $211.0K | $215.0K | $572.0K | $87.0K | $656.0K | $502.0K | -$70.0K | -$1.8M |
| Adjustments For Depreciation And Amortisation Expense | $1.2M | $1.6M | $1.4M | $1.5M | $145.0K | $232.0K | $315.0K | $58.0K | $94.0K | ||
| Adjustments For Employee Future Benefits | $436.0K | $288.0K | $520.0K | $295.0K | $161.0K | $217.0K | $262.0K | $316.0K | $246.0K | $382.0K | $351.0K |
| Operating Expense | $13.3M | $23.0M | $7.6M | $4.2M | $13.9M | $9.4M | $10.8M | $17.0M | $24.0M | $30.4M | $35.4M |
| Increase Decrease Through Sharebased Payment Transactions | -$14.0K | $464.0K | $192.0K | $69.0K | $311.0K | $61.0K | $793.0K | $570.0K | $182.0K | $1.1M | $869.0K |
| Other Adjustments For Noncash Items | $159.0K | $6.0K | $95.0K | $100.0K | $95.0K | $133.0K | -$126.0K | $35.0K | -$19.0K | -$83.0K | $154.0K |
| Issued Capital | $22.6M | $22.5M | $13.5M | $293.4M | $293.4M | $235.0M | $224.5M | $222.3M | $222.3M | $214.0M | |
| Other Finance Income Cost | -$13.0K | -$3.0K | -$21.0K | -$736.0K | -$593.0K | $278.0K | $75.0K | ||||
| Noncurrent Provisions For Employee Benefits | $11.0M | $11.7M | $12.6M | $11.2M | $17.5M | $15.4M | $13.8M | $13.2M | $14.2M | $13.4M | |
| Selling Expense | $1.4M | $1.1M | $1.2M | $3.1M | $5.1M | $6.7M | $6.9M | ||||
| Licence Fee Income | $1.7M | $911.0K | $74.0K | $24.3M | $458.0K | $497.0K | $248.0K | ||||
| Transaction Costs | -$3.2M | -$2.8M | $795.0K | $250.0K | |||||||
| Adjustments For Unrealised Foreign Exchange Losses Gains | -$179.0K | -$688.0K | -$87.0K | -$652.0K | -$553.0K | $87.0K | $1.6M | ||||
| Inventories Total | $229.0K | $73.0K | $21.0K | $1.2M | $240.0K | $554.0K | $0.00 | ||||
| Other Longterm Provisions | $243.0K | $279.0K | $308.0K | $411.0K | $1.0M | $501.0K |
Most recent annual filing with the SEC: March 25, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.